EP2185178
USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.7.2008EP published:
23.8.2017EP application number:
08796800.4
EPO information:
European Patent Register
Max expiry date:
29.7.2028
Title:
USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY
Timeline
Today
30.7.2008EP application
23.8.2017EP Publication
Owner
Name:
ELI LILLY AND COMPANYAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
COSKUN, TamerAddress:
Indianapolis, Indiana, US
Name:
GLAESNER, WolfgangAddress:
San Diego, CA, US
Priority
Number:
953785 PDate:
3.8.2007Country:
US
Classification
Categories:
A61K 38/18, A61K 38/26, A61P 3/04